Updated hourlyHourly refreshThu, Sep 3, 2026
Press Release Database
Recent press releases, indexed by topic.
Healthcare
(PR-inside.com) Coordinated model gives Critical Access and community hospitals a clear route from identifying specialist and transfer gaps to implementing and measuring sustainable virtual clinical services. PORTLAND, ME AND NEW YORK CITY, NY / ACCESS Newswire / September 2, 2026 / Stroudwater Associates, the nation's leading source for operational, financial, and clinical & quality strategy for rural and community healthcare, and Equum Medical, a physician-led acute care telehealth services company, today announced a strategic collaboration to provide Critical Access and rural hospitals a coordinated path to address specialist access gaps, patient outmigration, transfer patterns, workforce constraints and underperforming virtual care programs. Both ..
Sep 2 · 12:30·PR-Inside
Finance · Healthcare
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T) products for cancer and autoimmune disease, today announced that Geoffrey Parker, Executive Vice President and Chief Financial Officer, will retire effective November 6, 2026. Mr. Parker will continue to lead the finance organization through his retirement date as the Company conducts an external search for his successor.
Sep 2 · 12:30·GlobeNewswire
Finance · SaaS
TYLER, Texas, Sept. 02, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ: FEED) (“ENvue” or the “Company”), a commercial-stage medical device company focused on real-time guided bedside feeding tube placement, today announced it has been selected to exhibit its ENvue™ Navigation Platform, a minimally invasive electromagnetic navigation system guiding feeding tube placement, at the Vizient® Innovative Technology Exchange. Vizient , the nation’s largest provider-driven healthcare performance improvement company, will hold the Exchange on September 24, 2026 in Las Vegas, Nevada.
Sep 2 · 12:30·GlobeNewswire
Finance · SaaS
Meet with Modular Medical CEO Jeb Besser. Discover The Pivot tubeless patch pump, a simple, wearable insulin delivery platform designed to provide continuous subcutaneous insulin infusion with both basal and bolus insulin delivery over a three-day wear period. Explore How the Pivot represents a differentiated solution for insulin-dependent adults still on multiple daily injections, representing a multi-billion-dollar market opportunity . Register at PivotLaunch.TribePublic.com .
Sep 2 · 12:30·Newswire.com
Finance · Healthcare
MOUNTAIN VIEW, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or “the Company”) (Nasdaq: RNXT) , a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath ® , a patented, FDA-cleared drug-delivery device, today announced that Shaun Bagai, Chief Executive Officer, and Mark Voll, Chief Financial Officer, will present at the H.C. Wainwright 28th Annual Global Investment Conference . The conference will be held at the Lotte New York Palace Hotel in New York City, September 14-16, 2026.
Sep 2 · 12:30·GlobeNewswire
Finance · Healthcare
- Three posters to highlight preclinical activity of SLS009 (tambiciclib) across patient-derived KRAS mutant organoid models of pancreatic cancer –
Sep 2 · 12:30·GlobeNewswire
AI · Healthcare
(PR-inside.com) TORONTO, ON / ACCESS Newswire / September 2, 2026 / Datametrex AI Limited (the "Company" or "Datametrex'') (TSXV:DM)(FSE:D4G)(OTC PINK:DTMXF) is pleased to announce that it has initiated plans to wind down its health care operations. The wind-down is intended to allow the Company to focus its resources and management efforts on its core AI, data centre technology, and patent licensing businesses, optimize its current operations and resources, reduce operating and regulatory compliance requirements, and improve overall financial performance. As part of the wind-down process, the Company intends to gradually reduce and ultimately cease its health care operations, including the operation of its ..
Sep 2 · 12:00·PR-Inside
Healthcare
Vancouver, British Columbia--(Newsfile Corp. - September 2, 2026) - Apptly Health Technologies Corp. (CSE: APPT) (OTCQB: ESVNF) (the "Company" or "Apptly"), operator of the UberDoc direct-pay healthcare marketplace, today announced that it has been approved to trade on the OTCQB Venture Market ("OTCQB") in the United States under the symbol "ESVNF", effective September 2, 2026. The Company also confirms that its common shares are eligible for electronic clearing and settlement through the...
Sep 2 · 12:00·mlpr-newsfile
Finance · Healthcare
EMERYVILLE, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for cardiometabolic diseases by targeting the biology of human aging, today announced that the Company will participate in the following upcoming investor conferences:
Sep 2 · 12:00·GlobeNewswire
Finance · Healthcare
WATERTOWN, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that company management will participate in fireside chats at four upcoming investor conferences:
Sep 2 · 12:00·GlobeNewswire
AI · Healthcare
Beginning October 1, 2026, hospitals using Bayesian's continuous sepsis monitor can receive additional Medicare reimbursement for eligible inpatient cases, the first reimbursement pathway of its kind for presuspicion sepsis monitoring. NEW YORK, Sept. 2, 2026 /PRNewswire/ -- Bayesian...
Sep 2 · 11:54·PR Newswire
Finance · Healthcare
BOTHELL, Wash., September 02, 2026--Immunome, Inc. (Nasdaq: IMNM), a clinical-stage targeted oncology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that Immunome management will present at H.C. Wainwright’s 28th Annual Global Investment Conference on September 14, 2026, at 11:00 a.m.
Sep 2 · 11:45·mlpr-businesswire